The study was developed to compare outcomes of Aquablation in men with acute and chronic urinary retention.

METHODS We conducted a retrospective review of all men undergoing Aquablation resection of theprostate between May 2021 and August 2022.

Men were classified as having acute urinary retention if they required either intermittent or indwelling catheter and chronic urinary retentionif they had a postvoid residual > 300 mL prior to surgery. We compared success rates and time to passage of trial without catheter as well as complication rates to those with no retention.

Postoperative uroflow was obtained in the office or by thepatient using a smartphone and the MyUroflow app (MenHealth,San Francisco, CA) which has shown to be equivalent to in-office uroflow.

RESULTS A total of 113 men underwent Aquablation including 28 with acute retention and 16 withchronic retention. Failure of initial void trial was significantly higher in patients with preoperative urinary retention (40%) and chronic retention with postvoid residual > 300 mL(12.5%) compared to those with no retention (7.2%, P < .001). Among men with acute andchronic retention 98% were voiding spontaneously at a mean 5 months follow-up.

There was nodifference in utilization of postoperative prostate medications, complications, International Prostate Symptom Score or uroflowmetry among men with acute, chronic, or no retention.

CONCLUSION Aquablation is an effective method for treatment of men with urinary retention, with 98%achieving spontaneous voiding regardless of preoperative urodynamic findings. Men in acuteretention prior to surgery were more likely to fail their initial void trial, which may support therecommendation for a delayed trial without catheter.

UROLOGY 180: 214–218, 2023. © 2023Elsevier Inc. All rights reserved.

Abtract link:https://www.goldjournal.net/article/S0090-4295(23)00582-4/abstract